Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SET pseudogene 16 is a pseudogene, meaning it is a genomic sequence similar to a known protein-coding gene (likely related to SPT16 or SUPT16H), but it does not encode a functional protein due to disabling mutations, premature stop codons, or loss of coding capacity[3][2][6][5]. Most pseudogenes, including SET pseudogene 16, are not transcribed into protein and do not serve as drug targets, receptors, enzymes, or transporters. Some pseudogenes, in rare cases, may exhibit regulatory RNA functions such as acting as microRNA sponges or antisense regulators, but no such specific function has been described for SET pseudogene 16[3][2]. It is not considered a relevant biological target or therapeutic molecule.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SET pseudogene 16 (SETP16).